TMEM98 (NM 015544) Human Recombinant Protein – TP301829

Total Page：16

File Type：pdf, Size：1020Kb

TMEM98 (NM 015544) Human Recombinant Protein – TP301829

OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TP301829 TMEM98 (NM_015544) Human Recombinant Protein Product data: Product Type: Recombinant Proteins Description: Recombinant protein of human transmembrane protein 98 (TMEM98), transcript variant 1 Species: Human Expression Host: HEK293T Tag: C-Myc/DDK Predicted MW: 24.4 kDa Concentration: >50 ug/mL as determined by microplate BCA method Purity: > 80% as determined by SDS-PAGE and Coomassie blue staining Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol Bioactivity: Cell treatment (PMID: 25946230) Preparation: Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. Storage: Store at -80°C. Stability: Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. RefSeq: NP_056359 Locus ID: 26022 UniProt ID: Q9Y2Y6 RefSeq Size: 1808 Cytogenetics: 17q11.2 RefSeq ORF: 678 Synonyms: TADA1 Summary: This gene encodes a transmembrane protein. A missense mutation in this gene result in Nanophthalmos 4 (NNO4). Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2014] Protein Families: Transmembrane This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 TMEM98 (NM_015544) Human Recombinant Protein – TP301829 Product images: Coomassie blue staining of purified TMEM98 protein (Cat# TP301829). The protein was produced from HEK293T cells transfected with TMEM98 cDNA clone (Cat# [RC201829]) using MegaTran 2.0 (Cat# [TT210002]). This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 2 / 2.

Copy Link

Recommended publications

Genome-Wide Analysis Reveals Selection Signatures Involved in Meat Traits and Local Adaptation in Semi-Feral Maremmana Cattle
Genome-Wide Analysis Reveals Selection Signatures Involved in Meat Traits and Local Adaptation in Semi-Feral Maremmana Cattle Slim Ben-Jemaa, Gabriele Senczuk, Elena Ciani, Roberta Ciampolini, Gennaro Catillo, Mekki Boussaha, Fabio Pilla, Baldassare Portolano, Salvatore Mastrangelo To cite this version: Slim Ben-Jemaa, Gabriele Senczuk, Elena Ciani, Roberta Ciampolini, Gennaro Catillo, et al.. Genome-Wide Analysis Reveals Selection Signatures Involved in Meat Traits and Local Adaptation in Semi-Feral Maremmana Cattle. Frontiers in Genetics, Frontiers, 2021, 10.3389/fgene.2021.675569. hal-03210766 HAL Id: hal-03210766 https://hal.inrae.fr/hal-03210766 Submitted on 28 Apr 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License ORIGINAL RESEARCH published: 28 April 2021 doi: 10.3389/fgene.2021.675569 Genome-Wide Analysis Reveals Selection Signatures Involved in Meat Traits and Local Adaptation in Semi-Feral Maremmana Cattle Slim Ben-Jemaa 1, Gabriele Senczuk 2, Elena Ciani 3, Roberta
[Show full text]
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
[Show full text]
Product Datasheet Qprest
Product Datasheet QPrEST PRODUCT SPECIFICATION Product Name QPrEST TMM98 Mass Spectrometry Protein Standard Product Number QPrEST39234 Protein Name Transmembrane protein 98 Uniprot ID Q9Y2Y6 Gene TMEM98 Product Description Stable isotope-labeled standard for absolute protein quantification of Transmembrane protein 98. Lys (13C and 15N) and Arg (13C and 15N) metabolically labeled recombinant human protein fragment. Application Absolute protein quantification using mass spectrometry Sequence (excluding CRQRYCRPRDLLQRYDSKPIVDLIGAMETQSEPSELELDDVVITNPHIEA fusion tag) ILENEDWIEDASGLMSHCIAILKICHTLTEKLVAMTMGSGAKMKTSASVS Theoretical MW 28997 Da including N-terminal His6ABP fusion tag Fusion Tag A purification and quantification tag (QTag) consisting of a hexahistidine sequence followed by an Albumin Binding Protein (ABP) domain derived from Streptococcal Protein G. Expression Host Escherichia coli LysA ArgA BL21(DE3) Purification IMAC purification Purity >90% as determined by Bioanalyzer Protein 230 Purity Assay Isotopic Incorporation >99% Concentration >5 μM after reconstitution in 100 μl H20 Concentration Concentration determined by LC-MS/MS using a highly pure amino acid analyzed internal Determination reference (QTag), CV ≤10%. Amount >0.5 nmol per vial, two vials supplied. Formulation Lyophilized in 100 mM Tris-HCl 5% Trehalose, pH 8.0 Instructions for Spin vial before opening. Add 100 μL ultrapure H2O to the vial. Vortex thoroughly and spin Reconstitution down. For further dilution, see Application Protocol. Shipping Shipped at ambient temperature Storage Lyophilized product shall be stored at -20°C. See COA for expiry date. Reconstituted product can be stored at -20°C for up to 4 weeks. Avoid repeated freeze-thaw cycles. Notes For research use only Product of Sweden. For research use only. Not intended for pharmaceutical development, diagnostic, therapeutic or any in vivo use.
[Show full text]
Supplemental Figure 1
Supplemental Figure 1 Developmentally regulated gene expression in WT NOD and B6 thymocytes. (A) Gene expression of tyrosine receptor kinase Epha2 is higher in NOD than B6 at all developmental stages. (B) Expression of Dapk1 is lower in NOD than B6 at all developmental stages, and off in NOD DN2a cells. Relative developmentally regulated expression in B6 subsets was confirmed using publicly available data from immgen.org. Supplemental Table 1. Genes differentially expressed >3X between NOD.Rag and B6.Rag CD25+DN thymocytes QTL or Log2 RPKM3 Gene Description congenic Chr Start Bp2 1 region B44 B7 N4 N7 Gm5828 predicted gene 5828 1 16,757,095 0.74 0.72 2.45 2.15 Efhc1 EF-hand domain (C-terminal) containing 1 1 20,941,707 0.94 1.01 0.13 0.13 Gm4956 predicted gene 4956 1 21,275,327 0.12 0.32 0.02 0.01 Khdc1a KH domain containing 1A 1 21,339,722 80.46 166.88 3.18 0.95 Khdc1c KH domain containing 1C 1 21,358,412 18.91 40.51 2.67 1.03 Khdc1b KH domain containing 1B 1 21,373,637 2.09 5.08 0.15 0.11 Gm8210 predicted pseudogene 8210 1 43,246,001 0.69 0.83 24.86 27.78 Gm8251 predicted gene 8251 1 44,112,797 0.12 0.24 0.06 0.03 Gm5527 predicted gene 5527 1 52,638,932 0.10 0.14 1.18 1.15 Ctla4 cytotoxic T-lymphocyte-associated protein 4 1 60,943,844 27.56 44.78 8.13 4.05 Obsl1 obscurin-like 1 1 75,475,885 0.21 0.01 0.76 0.58 Agfg1 ArfGAP with FG repeats 1 1 82,836,058 45.51 38.88 14.72 12.69 Gm7582 predicted gene 7582 1 85,024,529 0.08 0.12 0.89 1.42 A530032D15Rik RIKEN cDNA A530032D15Rik gene 1 85,084,714 0.50 0.91 2.66 3.2 Gm7609 predicted pseudogene
[Show full text]
Autosomal Dominant Nanophthalmos and High Hyperopia Associated with a C-Terminal Frameshift Variant in MYRF
Molecular Vision 2019; 25:527-534 <http://www.molvis.org/molvis/v25/527> © 2019 Molecular Vision Received 23 June 2019 | Accepted 19 September 2019 | Published 21 September 2019 Autosomal dominant nanophthalmos and high hyperopia associated with a C-terminal frameshift variant in MYRF Owen M. Siggs,1 Emmanuelle Souzeau,1 James Breen,2 Ayub Qassim,1 Tiger Zhou,1 Andrew Dubowsky,3 Jonathan B. Ruddle,4 Jamie E. Craig1 1Department of Ophthalmology, Flinders University, Bedford Park, South Australia, Australia; 2South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; 3SA Pathology, Flinders Medical Centre, Adelaide, Australia; 4Department of Ophthalmology, University of Melbourne, Melbourne, Victoria, Australia Purpose: Nanophthalmos is a rare subtype of microphthalmia associated with high hyperopia and an increased risk of angle-closure glaucoma. We investigated the genetic cause of nanophthalmos and high hyperopia in an autosomal dominant kindred. Methods: A proband with short axial length, high hyperopia, and dextrocardia was subjected to exome sequencing. Human and rodent gene expression data sets were used to investigate the expression of relevant genes. Results: We identified a segregating heterozygous frameshift variant at the 3′ end of the penultimate exon of MYRF. Using Myc-MYRF chromatin immunoprecipitation data from rat oligodendrocytes, MYRF was found to bind immedi- ately upstream of the transcriptional start site of Tmem98, a gene that itself has been implicated in autosomal dominant nanophthalmos. MYRF and TMEM98 were found to be expressed in the human retina, with a similar pattern of expression across several dissected human eye tissues. Conclusions: C-terminal variants in MYRF, which are expected to escape nonsense-mediated decay, represent a rare cause of autosomal dominant nanophthalmos with or without dextrocardia or congenital diaphragmatic hernia.
[Show full text]
UNIVERSITY of CALIFORNIA RIVERSIDE Impact of Alcohol on Intestinal Homeostasis a Dissertation Submitted in Partial Satisfaction
UNIVERSITY OF CALIFORNIA RIVERSIDE Impact of Alcohol on Intestinal Homeostasis A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences by Tasha Marie Barr June 2018 Dissertation Committee: Dr. Ilhem Messaoudi, Co-Chairperson Dr. Declan McCole, Co-Chairperson Dr. James Borneman Copyright by Tasha Marie Barr 2018 The Dissertation of Tasha Marie Barr is approved: Committee Co-Chairperson Committee Co-Chairperson University of California, Riverside ACKNOWLEDGEMENTS To Dr. Ilhem Messaoudi: Thank you for never giving up on me and for the countless talks and words of encouragement. You are such an inspiration and your incredibly strong work ethic is my motivation. You have shown me what it takes to be a successful scientist and I will be forever grateful for you taking a chance with me. To the Messsaoudi Lab: Thank you all for the support you have given me over these years. I was fortunate to have amazing lab mates that are truly my best friends. Special thanks to Andrea – I am so grateful I had you by my side throughout this adventure. To Dr. Declan McCole and Dr. James Borneman: Thank you for agreeing to be on my committee. I truly do appreciate the both of you taking the time out of your busy days to give me advice and forcing me to think critically like a biomedical scientist. The text of this dissertation, in part or in full, is a reprint of the material as it appears in Progress in Neuro-Psychopharmacology and Biological Psychiatry 2016 (Chapter 1); Journal of Immunology 2016 (Chapter 2); and Gut Microbes 2018 (Chapter 3).
[Show full text]
Missense Mutations in the Human Nanophthalmos Gene TMEM98 Cause Retinal Defects in the Mouse
Genetics Missense Mutations in the Human Nanophthalmos Gene TMEM98 Cause Retinal Defects in the Mouse Sally H. Cross,1 Lisa Mckie,1 Margaret Keighren,1 Katrine West,1 Caroline Thaung,2,3 Tracey Davey,4 Dinesh C. Soares,*,1 Luis Sanchez-Pulido,1 and Ian J. Jackson1 1MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom 2Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom 3University College London Institute of Ophthalmology, London, United Kingdom 4Electron Microscopy Research Services, Newcastle University, Newcastle, United Kingdom Correspondence: Sally H. Cross, PURPOSE. We previously found a dominant mutation, Rwhs, causing white spots on the retina MRC Human Genetics Unit, MRC accompanied by retinal folds. Here we identify the mutant gene to be Tmem98. In humans, Institute of Genetics and Molecular mutations in the orthologous gene cause nanophthalmos. We modeled these mutations in Medicine, University of Edinburgh, mice and characterized the mutant eye phenotypes of these and Rwhs. Crewe Road, Edinburgh EH4 2XU, UK; METHODS. The Rwhs mutation was identified to be a missense mutation in Tmem98 by genetic [email protected]. mapping and sequencing. The human TMEM98 nanophthalmos missense mutations were Current affiliation: *ACS International made in the mouse gene by CRISPR-Cas9. Eyes were examined by indirect ophthalmoscopy Ltd., Oxford, United Kingdom and the retinas imaged using a retinal camera. Electroretinography was used to study retinal function. Histology, immunohistochemistry, and electron microscopy techniques were used Submitted: October 10, 2018 Accepted: May 28, 2019 to study adult eyes. Citation: Cross SH, Mckie L, Keighren RESULTS.
[Show full text]
Identification of Expression Qtls Targeting Candidate Genes For
ISSN: 2378-3648 Salleh et al. J Genet Genome Res 2018, 5:035 DOI: 10.23937/2378-3648/1410035 Volume 5 | Issue 1 Journal of Open Access Genetics and Genome Research RESEARCH ARTICLE Identification of Expression QTLs Targeting Candidate Genes for Residual Feed Intake in Dairy Cattle Using Systems Genomics Salleh MS1,2, Mazzoni G2, Nielsen MO1, Løvendahl P3 and Kadarmideen HN2,4* 1Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark Check for 2Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark updates 3Department of Molecular Biology and Genetics-Center for Quantitative Genetics and Genomics, Aarhus University, AU Foulum, Tjele, Denmark 4Department of Applied Mathematics and Computer Science, Technical University of Denmark, Lyngby, Denmark *Corresponding author: Kadarmideen HN, Department of Applied Mathematics and Computer Science, Technical University of Denmark, DK-2800, Kgs. Lyngby, Denmark, E-mail: [email protected] Abstract body weight gain and net merit). The eQTLs and biological pathways identified in this study improve our understanding Background: Residual feed intake (RFI) is the difference of the complex biological and genetic mechanisms that de- between actual and predicted feed intake and an important termine FE traits in dairy cattle. The identified eQTLs/genet- factor determining feed efficiency (FE). Recently, 170 can- ic variants can potentially be used in new genomic selection didate genes were associated with RFI, but no expression methods that include biological/functional information on quantitative trait loci (eQTL) mapping has hitherto been per- SNPs. formed on FE related genes in dairy cows. In this study, an integrative systems genetics approach was applied to map Keywords eQTLs in Holstein and Jersey cows fed two different diets to eQTL, RNA-seq, Genotype, Data integration, Systems improve identification of candidate genes for FE.
[Show full text]
TMEM98 (C-18): Sc-241083
SAN TA C RUZ BI OTEC HNOL OG Y, INC . TMEM98 (C-18): sc-241083 BACKGROUND PRODUCT TMEM98 (transmembrane protein 98), also known as TADA1, is a 226 Each vial contains 200 µg IgG in 1.0 ml of PBS with < 0.1% sodium azide amino acid protein encoded by a gene mapping to human chromosome 17. and 0.1% gelatin. Chromosome 17 makes up over 2.5% of the human genome with about 81 Blocking peptide available for competition studies, sc-241083 P, (100 µg million bases encoding over 1,200 genes. Two key tumor suppressor genes peptide in 0.5 ml PBS containing < 0.1% sodium azide and 0.2% BSA). are associated with chromosome 17, namely, p53 and BRCA1. Tumor sup pres - sor p53 is necessary for maintenance of cellular genetic integrity by moder at - APPLICATIONS ing cell fate through DNA repair versus cell death. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syn - TMEM98 (C-18) is recommended for detection of TMEM98 of mouse, rat and drome. Like p53, BRCA1 is directly involved in DNA repair, though specifical ly human origin by Western Blotting (starting dilution 1:200, dilution range it is recognized as a genetic determinant of early onset breast cancer and pre - 1:100-1:1000), immunofluorescence (starting dilution 1:50, dilution range disposition to cancers of the ovary, colon, prostate gland and fallopian tubes. 1:50-1:500) and solid phase ELISA (starting dilution 1:30, dilution range Chromosome 17 is also linked to neurofibromatosis, a condition character ized 1:30-1:3000).
[Show full text]
Characterizing Genomic Duplication in Autism Spectrum Disorder by Edward James Higginbotham a Thesis Submitted in Conformity
Characterizing Genomic Duplication in Autism Spectrum Disorder by Edward James Higginbotham A thesis submitted in conformity with the requirements for the degree of Master of Science Graduate Department of Molecular Genetics University of Toronto © Copyright by Edward James Higginbotham 2020 i Abstract Characterizing Genomic Duplication in Autism Spectrum Disorder Edward James Higginbotham Master of Science Graduate Department of Molecular Genetics University of Toronto 2020 Duplication, the gain of additional copies of genomic material relative to its ancestral diploid state is yet to achieve full appreciation for its role in human traits and disease. Challenges include accurately genotyping, annotating, and characterizing the properties of duplications, and resolving duplication mechanisms. Whole genome sequencing, in principle, should enable accurate detection of duplications in a single experiment. This thesis makes use of the technology to catalogue disease relevant duplications in the genomes of 2,739 individuals with Autism Spectrum Disorder (ASD) who enrolled in the Autism Speaks MSSNG Project. Fine-mapping the breakpoint junctions of 259 ASD-relevant duplications identified 34 (13.1%) variants with complex genomic structures as well as tandem (193/259, 74.5%) and NAHR- mediated (6/259, 2.3%) duplications. As whole genome sequencing-based studies expand in scale and reach, a continued focus on generating high-quality, standardized duplication data will be prerequisite to addressing their associated biological mechanisms. ii Acknowledgements I thank Dr. Stephen Scherer for his leadership par excellence, his generosity, and for giving me a chance. I am grateful for his investment and the opportunities afforded me, from which I have learned and benefited. I would next thank Drs.
[Show full text]
Computational Proteogenomic Identification and Functional
bioRxiv preprint doi: https://doi.org/10.1101/168377; this version posted July 25, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Computational proteogenomic identification and functional interpretation of translated fusions and micro structural variations in cancer Yen Yi Lin1;y, Alexander Gawronski1;y, Faraz Hach1;3;y, Sujun Li2, Ibrahim Numanagic,´ 1, Iman Sarrafi1;3, Swati Mishra5, Andrew McPherson1, Colin Collins3;4, Milan Radovich5, Haixu Tang2, S. Cenk Sahinalp 1;2;3; ∗ 1School of Computing Science, Simon Fraser University, Burnaby, BC, Canada, 2School of Informatics and Computing, Indiana University, Bloomington, IN, USA, 3Vancouver Prostate Centre, Vancouver, BC, Canada, 4Dept. of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada 5Department of Surgery, Indiana University, School of Medicine, Indianapolis, IN, USA Motivation: Rapid advancement in high throughput genome and transcriptome sequencing (HTS) and mass spectrometry (MS) technologies has enabled the acquisition of the genomic, transcriptomic and proteomic data from the same tissue sample. In this paper we in- troduce a novel computational framework which can integratively analyze all three types of omics data to obtain a complete molecular profile of a tissue sample, in normal and disease conditions. Our framework includes MiStrVar, an algorithmic method we developed to identify micro structural variants (microSVs) on genomic HTS data. Coupled with deFuse, a popular gene fusion detection method we devel- oped earlier, MiStrVar can provide an accurate profile of structurally aberrant tran- scripts in cancer samples. Given the breakpoints obtained by MiStrVar and deFuse, our framework can then identify all relevant peptides that span the breakpoint junc- tions and match them with unique proteomic signatures in the respective proteomics data sets.
[Show full text]
Mutation in TMEM98 in a Large White Kindred with Autosomal Dominant Nanophthalmos Linked to 17P12-Q12
Research Original Investigation Mutation in TMEM98 in a Large White Kindred With Autosomal Dominant Nanophthalmos Linked to 17p12-q12 Mona S. Awadalla, MBBS, PhD; Kathryn P. Burdon, PhD; Emmanuelle Souzeau, MSc; John Landers, MBBS, MPH, PhD; Alex W. Hewitt, MBBS, PhD; Shiwani Sharma, PhD; Jamie E. Craig, MBBS, DPhil Supplemental content at IMPORTANCE Nanophthalmos is a congenital disorder characterized by small eyes, with the jamaophthalmology.com main complications being severe hyperopia and angle-closure glaucoma. OBJECTIVE To perform a clinical and genetic investigation of a large white family with autosomal dominant nanophthalmos. DESIGN, SETTING, AND PARTICIPANTS Detailed clinical evaluation and a genome-wide linkage scan was conducted in the family NNO-SA1. Linkage was evaluated with a 10K single-nucleotide polymorphism array, followed by whole exome sequencing, to identify novel segregating coding variants within the linked region. The candidate gene was screened for mutations in additional independent families by direct sequencing of the coding exons and intron/exon boundaries. The expression pattern of the candidate gene in ocular tissues was analyzed by reverse transcriptase–polymerase chain reaction. Participants were recruited through ophthalmology clinics at Flinders Medical Centre, Adelaide, South Australia, Australia. Nanophthalmos was defined as an axial length less than 20.0 mm and/or refractive error greater than +7.00. Of the 35 available individuals from family NNO-SA1, 16 participants (46%) had a diagnosis of nanophthalmos, with mean refraction of +11.8 D and mean axial length of 17.6 mm. Unaffected unrelated individuals serving as controls were screened for the identified mutation. Additional independent families with clinically diagnosed nanophthalmos were also recruited.
[Show full text]